Zosano Pharma Corporation (ZSAN) Financials

NASDAQ Currency in USD Disclaimer

$0.56

north_east NA Past Year
Day's range
$0.46
Day's range
$0.64
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning2015201520162016201720172018201820192019202020202021202110000%10000%5000%5000%0%0%-5000%-5000%-10000%-10000%-15000%-15000%Profit Margin
Profit Margin
Revenue
Earnings

ZSAN Income statement / Annual

Last year (2021), Zosano Pharma Corporation's total revenue was $785,000.00, an increase of 250.45% from the previous year. In 2021, Zosano Pharma Corporation's net income was -$30.11 M. See Zosano Pharma Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $785,000.00 $224,000.00 $0.00 $0.00 $0.00 $0.00 $313,000.00 $2.86 M $4.25 M $11.62 M
Cost of Revenue $796,000.00 $171,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100,000.00 $0.00 $0.00
Gross Profit -$11,000.00 $53,000.00 $0.00 $0.00 $0.00 $0.00 $313,000.00 $2.76 M $4.25 M $11.62 M
Gross Profit Ratio -0.01 0.24 0 0 0 0 1 0.97 1 1
Research and Development Expenses $20.97 M $21.62 M $25.39 M $25.51 M $20.19 M $20.46 M $20.37 M $10.95 M $7.64 M $5.40 M
General & Administrative Expenses $10.55 M $11.19 M $11.81 M $9.36 M $8.18 M $8.18 M $6.32 M $4.42 M $4.58 M $3.08 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.55 M $11.19 M $11.81 M $9.36 M $8.18 M $8.18 M $6.32 M $4.42 M $4.58 M $3.08 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $31.52 M $32.81 M $37.20 M $34.87 M $28.37 M $28.63 M $26.68 M $15.37 M $12.22 M $8.48 M
Cost And Expenses $32.32 M $32.98 M $37.20 M $34.87 M $28.37 M $28.63 M $26.68 M $15.47 M $12.22 M $8.48 M
Interest Income $3,000.00 $18,000.00 $207,000.00 $381,000.00 $0.00 $0.00 $235,000.00 $0.00 $0.00 $0.00
Interest Expense $189,000.00 $719,000.00 $523,000.00 $379,000.00 $742,000.00 $0.00 $1.80 M $0.00 $0.00 $0.00
Depreciation & Amortization $1.75 M $1.43 M $683,000.00 $764,000.00 $2.55 M $2.54 M $2.45 M $3.04 M $428,000.00 $1.07 M
EBITDA -$27.99 M -$31.22 M -$36.38 M -$34.22 M -$25.81 M -$27.29 M -$24.18 M -$11.20 M -$5.18 M $2.89 M
EBITDA Ratio -35.65 -139.39 0 0 0 0 -77.24 -3.91 -1.22 0.25
Operating Income Ratio -37.88 -146.24 0 0 0 0 -84.24 -4.41 -1.88 0.27
Total Other Income/Expenses Net -$189,000.00 -$611,000.00 -$392,000.00 $18,000.00 -$735,000.00 -$1.20 M -$2.06 M -$1.63 M $2.36 M -$1.33 M
Income Before Tax -$29.93 M -$33.37 M -$37.59 M -$35.36 M -$29.11 M -$29.83 M -$28.43 M -$14.24 M -$5.61 M $1.82 M
Income Before Tax Ratio -38.12 -148.97 0 0 0 0 -90.82 -4.98 -1.32 0.16
Income Tax Expense $189,000.00 $108,000.00 $131,000.00 $397,000.00 $7,000.00 -$1.20 M -$260,000.00 -$1.63 M $2.36 M -$1.33 M
Net Income -$30.11 M -$33.37 M -$37.59 M -$35.36 M -$29.11 M -$29.83 M -$28.43 M -$14.24 M -$5.61 M $1.82 M
Net Income Ratio -38.36 -148.97 0 0 0 0 -90.82 -4.98 -1.32 0.16
EPS -0.27 -0.49 -2.29 -3.74 -16.82 -43.32 -49.81 -24.52 -21.52 6.98
EPS Diluted -0.27 -0.49 -2.29 -3.74 -16.82 -43.32 -49.81 -24.52 -21.52 6.98
Weighted Average Shares Out $112.06 M $67.91 M $16.38 M $9.45 M $1.73 M $688,650.00 $570,700.00 $580,805.00 $260,550.00 $260,550.00
Weighted Average Shares Out Diluted $112.06 M $67.91 M $16.38 M $9.45 M $1.73 M $688,650.00 $570,700.00 $580,805.00 $260,550.00 $260,550.00
Link